Beijing Cancer Hospital — Beijing

Public research footprint of Beijing Cancer Hospital, compiled from the ClinicalTrials.gov public registry.

1,177

Registered studies

522

Active

302

Recruiting now

308

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer (NSCLC) · Solid Tumors · Breast Neoplasms · B-cell Non-Hodgkin Lymphoma (B-NHL)

Recently updated registry entries

NCT07227597 — A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People… (Recruiting)
NCT07431827 — MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC… (Recruiting)
NCT06305754 — Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Beijing Cancer Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.